DRTG(SH:600329)2025-07-14 08:50Current Period Performance Forecast The company forecasts H1 2025 net profit attributable to shareholders to significantly increase due to one-time gains, while core business net profit is expected to decline 2025 H1 Performance Forecast | Indicator | 2025 H1 Forecast | YoY Change | YoY Growth Rate | | :--- | :--- | :--- | :--- | | Net Profit Attributable to Shareholders | 1.84 billion CNY - 2.00 billion CNY | Increase of 1.182 billion CNY - 1.342 billion CNY | +180% to +204% | | Net Profit Attributable to Shareholders (Excluding Non-Recurring Items) | 560 million CNY - 620 million CNY | Decrease of 13.83 million CNY - 73.83 million CNY | -2% to -12% | - The data contained in this performance forecast has not been audited by a certified public accountant5 Prior Period Operating Performance and Financial Status This section reviews H1 2024 financial performance, including net profit attributable to shareholders, non-recurring adjusted net profit, and earnings per share 2024 H1 Operating Performance | Indicator (2024 H1) | Amount | | :--- | :--- | | Net Profit Attributable to Owners of Parent Company | 657.72 million CNY | | Net Profit Attributable to Shareholders (Excluding Non-Recurring Items) | 633.83 million CNY | | Earnings Per Share | 0.85 CNY | Primary Reasons for Performance Increase in Current Period The significant increase in net profit is attributed to a one-time gain from an equity sale, while the decline in core net profit is due to the cessation of associate investment income - The substantial increase in net profit attributable to shareholders is primarily due to the sale of a 12% equity stake in associate company Sino-American Tianjin SmithKline Pharmaceutical Co., Ltd., realizing a post-tax net profit of 1.31 billion CNY7 - Net profit excluding non-recurring items decreased year-over-year, mainly because investment income from Tianjin SmithKline is no longer recognized after the equity sale, whereas this income was 110 million CNY in the prior year period7 Risk Warning The company highlights that the performance forecast is a preliminary, unaudited estimate, though no significant uncertainties are identified - This performance forecast is a preliminary calculation by the company's finance department and has not been audited by a certified public accountant, but the company believes there are no significant uncertainties8 Other Explanatory Matters Investors are advised that the forecast data is preliminary, and final accurate financial figures will be based on the official 2025 semi-annual report - The final accurate financial data will be subject to the company's officially disclosed 2025 semi-annual report, and investors are reminded to be aware of investment risks910